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Gamma frequency oscillations (γ, 30–100 Hz) have been suggested to underlie various
cognitive and motor functions. The psychotomimetic drug methamphetamine (MA)
enhances brain γ oscillations associated with changes in psychomotor state. Little is
known about the cellular mechanisms of MA modulation on γ oscillations. We explored
the effects of multiple intracellular kinases on MA modulation of γ induced by kainate
in area CA3 of rat ventral hippocampal slices. We found that dopamine receptor type
1 and 2 (DR1 and DR2) antagonists, the serine/threonine kinase PKB/Akt inhibitor and
N-methyl-D-aspartate receptor (NMDAR) antagonists prevented the enhancing effect of
MA on γ oscillations, whereas none of them affected baseline γ strength. Protein kinase
A, phosphoinositide 3-kinase and extracellular signal-related kinases inhibitors had no
effect on MA. We propose that the DR1/DR2-Akt-NMDAR pathway plays a critical role
for the MA enhancement of γ oscillations. Our study provides an new insight into the
mechanisms of acute MA on MA-induced psychosis.
Keywords: methamphetamine, γ oscillation, hippocampus, Akt/PKB, DR, NMDAR
INTRODUCTION
Neuronal synchronization at γ frequency band (30–100 Hz, γ oscillations) emerges from activated
neuronal networks, consisting of mutually connected principal cells and inhibitory cells (Fisahn
et al., 1998). γ oscillations provide a millisecond-precision timing matrix that facilitates inter-
neuronal communication and information transfer (Akam and Kullmann, 2014). In addition to
synchronizing neuronal activity locally, oscillatory activity contributes to inter-region or long-range
synchronization (Konig et al., 1995, Colgin, 2011, Fries, 2015). γ oscillations are implicated in a
variety of cognitive functions, including attention, perceptual binding and memory (Womelsdorf
et al., 2007, Buzsaki and Wang, 2012). Interestingly, γ oscillations have been associated with lucid
dreaming and emotion processes (Garcia-Garcia et al., 2010, Scarpelli et al., 2019).
Aberrant γ oscillations have been considered as a biomarker of a variety of neurological
and psychiatric disorders, including Alzheimer’s disease (Mably and Colgin, 2018), ADHD
(Barry and Clarke, 2013), schizophrenia and major depression (Yener and Basar, 2013,
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Fitzgerald and Watson, 2018). Enhanced γ oscillation power
has been associated with psychosis. γ oscillation abnormalities
in schizophrenia include abnormal increases in baseline
power as well as deficits in evoked oscillations (Hirano
et al., 2015). The psychotomimetic drug methamphetamine
(MA) causes psychosis in users that resemble positive
symptoms of schizophrenia (Wearne and Cornish, 2018).
MA enhances γ oscillations in the nucleus accumbens and
causes psychosis-like repetitive behaviors in rodents (Morra
et al., 2012). Amphetamine, a metabolite of MA, enhances
γ oscillations in the neocortex (Pinault, 2008; Qi et al.,
2018) and hippocampus (Leung and Ma, 2018). Whereas
hippocampal γ oscillations are crucially involved in a triangular
relation with the nucleus accumbens and prefrontal cortex
(Ma and Leung, 2010), the effect of MA on hippocampal γ
oscillations is yet unknown.
γ oscillations can be reliably induced in the hippocampus
in vitro by the glutamate receptor agonist kainate (KA)
(Cunningham et al., 2003; Ainsworth et al., 2011; Lu et al., 2012;
Balleza-Tapia et al., 2018). Although at higher concentration
KA can cause epileptiform activity in the hippocampus
(Fisher and Alger, 1984), at low concentration KA reliably
induces γ oscillations (Hajos et al., 2000), which show
a high degree of similarity with γ oscillations in vivo
(Butler and Paulsen, 2015), including the crucial role of
fast-spiking perisomatic parvalbumin-containing interneurons
(Fisahn et al., 2004; Mann and Paulsen, 2005; Bartos et al.,
2007; Ainsworth et al., 2011; Buzsaki and Wang, 2012).
Furthermore, in vitro hippocampal γ power can serve as an
index of in vivo CA3 γ strength (Lu et al., 2011). Whereas
in vivo, hippocampal γ oscillation power is modulated by
the theta rhythm, driven by the medial septum, and by
other midbrain influences, KA-induced γ oscillations in acute
hippocampal slices provide a model to study γ generating
network in isolation, which allows for the study of the
effect of MA on cellular and molecular properties in the γ
generating network.
Several pathways affected by MA may be implicated
in the modulation of hippocampal γ oscillations. MA
increases extracellular dopamine levels both by inhibiting
the dopamine transporter and by increasing dopamine release
(Ares-Santos et al., 2013), probably through activation of
trace amine-associated receptor 1, which inhibits uptake
and promoting eﬄux by monoamine transporters (Miller,
2011). MA affects dopamine-mediated intracellular signaling
pathways (Sulzer, 2011), like the classical cAMP-protein
kinase A (PKA) pathway, which is activated by DR1 activation
and inhibited by DR2 activation. Other pathways involved
include phosphoinositide 3-kinase (PI3K)-dependent or
independent Akt signaling (Beaulieu et al., 2007a) and
extracellular signal-regulated kinase (ERK), which is activated
by both DR1 and DR2 agonists (Brami-Cherrier et al., 2002;
Beaulieu et al., 2011).
Since acute application of MA increases brain glutamate
concentration, GluN2B-mediated synaptic currents (Li et al.,
2017) and NR1 expression (Kerdsan et al., 2009), altered
NMDAR-mediated pathways may modulate γ oscillations, as
previously shown by nicotine (Wang et al., 2015) or ethanol
(Wang et al., 2016).
In this study, we test the role of acute MA on hippocampal
γ oscillations in vitro and what signaling pathways are involved
in MA modulation of γ. We found that MA caused a
robust enhancement of hippocampal γ oscillations, through the
activation of DR-Akt-NMDAR signaling pathways.
MATERIALS AND METHODS
Animals
All animal use procedures were approved by the Ethics
Committees at the Xinxiang Medical University for the Care
and Use of Laboratory Animals, and all efforts were made to
minimize animal suffering and the number of animals used.
Ventral hippocampal slices were prepared from Sprague Dawley
rats (male, 4–5 week-old). The animals were anesthetized by
intraperitoneal injection of Sagatal (sodium pentobarbitone,
100 mg kg−1, Rhône Mérieux Ltd., Harlow, United Kingdom).
When all pedal reflexes were abolished, the animals were
perfused intracardially with chilled (5◦C), oxygenated artificial
cerebrospinal fluid (ACSF) in which the sodium chloride
had been replaced by iso-osmotic sucrose. This sucrose-ACSF
contained (in mM): 225 sucrose, 3 KCl, 1.25 NaH2PO4, 24
NaHCO3, 6 MgSO4, 0.5 CaCl2, and 10 glucose (pH: 7.4).
Horizontal slices (400 µm) of rat brain were cut at 5◦C in
the sucrose-ACSF, using a Leica VT1000S vibratome (Leica
Microsystems, Milton Keynes, United Kingdom) and stored at
room temperature at the interface between recording ACSF and
humidified carbogen (95% O2–5% CO2) until transferred to the
recording chamber. The recording ACSF contained (in mM): 126
NaCl, 3 KCl, 1.25 NaH2PO4, 24 NaHCO3, 2 MgSO4, 2 CaCl2, and
10 Glucose (pH: 7.4).
Electrophysiological Recording, Data
Acquisition and Analysis
In the Haas type recording chamber, hippocampal slices
were maintained at a temperature of 32◦C at the interface
between ACSF and warm humidified carbogen and were
allowed to equilibrate in this medium for 1 h prior to
recording. Extracellular field potentials were recorded from
stratum pyramidale of CA3c, using glass microelectrodes
containing ACSF (resistance 2–5 M). Field potentials were
amplified by Neurolog NL106 AC/DC amplifiers (Digitimer
Ltd., Welwyn Garden City, United Kingdom) and band-pass
filtered between 0.5 Hz and 2 kHz using Neurolog NL125 filters
(Digitimer). Electromagnetic interference from the mains supply
was eliminated from the recordings with the use of Humbug
50 Hz noise eliminators (Digitimer Ltd.). The recordings were
digitized at a sample rate of 5–10 kHz using a CED 1401
plus ADC board (Cambridge Electronic Design, Cambridge,
United Kingdom).
Data were analyzed off-line using Spike-2 software
(Cambridge Electronic Design). Power spectra were generated
to provide a quantitative measure of the frequency components.
Power spectra were constructed for 60 s epochs using a fast
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Fourier transform algorithm. The area under the curve between
20 and 60 Hz was used to quantify the γ power.
All statistical tests were performed using SigmaStat
software (Sysstat software, San Jose, CA, United States).
Since data sets were not different from normal distributions,
results are expressed as mean ± standard error of mean.
Comparisons within slices were made with paired Student’s
t-test. Comparisons between the effect of a drug and
changes in time-matched controls were made with unpaired
Student’s t-test. The effect of MA concentrations was tested
by one-way ANAOVA.
Effects were considered statistically significant, if P < 0.05.
Drugs
Methamphetamine was purchased from the National Institute
for Food and Drug Control (Beijing, China). The selective
DR1 antagonist SCH23390, DR2 antagonist raclopride, the
mitogen-activated protein kinase inhibitor U0126 and the PI3K
FIGURE 1 | The influence of MA on KA-induced γ oscillations. (A) Typical example of the development of γ power in hippocampal area CA3, as function of time after
the start of KA (200 µM). After γ power stabilized, MA (20 µM) was added. (B) Example of γ oscillations recorded in area CA3, induced by KA and after addition of
MA. (C) Power spectra of the oscillatory activity in KA alone (black line) and after MA application (red line) for the slice in B. (D) The γ power (normalized to the KA
only baseline value for continued KA only application (control) and for MA application at various concentrations (∗P < 0.05; ∗∗P < 0.01; ∗∗∗P < 0.001). (E) Peak
frequency of γ oscillations before and after MA application at various concentrations (details as in D). (F) Example of activity recorded in control aCSF and after
application of MA (20 µM). (G) Power spectra of the oscillatory activity in control (black line) and after MA application (red line) for the slice in F.
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inhibitor wortmannin were purchased from Tocris Cookson Ltd.
(Bristol, United Kingdom). The Akt/PKB inhibitor triciribine
PKA inhibitor H89, NMDAR antagonist D-AP5 and the kainate
receptor agonist kainate (KA) were obtained from Sigma-Aldrich
(United Kingdom).
Stock solutions, at thousand times the final concentration,
were made up in water or in DMSO, and stored in individual
aliquots at −20◦C. Final solutions were prepared freshly on the
day of the experiment.
RESULTS
MA Increases Kainate-Induced γ
Oscillations
To investigate the effect of MA on the γ oscillation-generating
network in area CA3, without modulatory influences of other
brain areas, γ oscillations were induced in the hippocampal
CA3 in vitro. The CA3 network was activated by perfusing
hippocampal slices with 200 nM KA (Hajos et al., 2000).
γ oscillation amplitude reached a steady state usually after
40–120 min application of KA (example in Figure 1A, with a
γ power of 1586 ± 528 µV2 (n = 30) and a peak frequency of
26.6 ± 1.0 Hz (n = 30, example in Figures 1B,C). MA was then
added to the ACSF (2 µM, 20 µM, or 100 µM) and perfused
for 60 min. MA concentration-dependently increased γ power
by 79 ± 27% [t(6) = −2.94, P = 0.026] for 2 µM, by 152 ± 32%
[t(14) = −2.94, P = 0.001, example in Figures 1B,C] for 20 µM
and by 300 ± 77% [t(10) = −3.86, P = 0.003] for 100 µM
MA. The MA-induced increase in γ power was concentration-
dependent [F(2,30) = 3.977, P = 0.0132, Figure 1D]. MA did
not affect the peak frequency of γ oscillations [F(3,39) = 0.32,
P = 0.815, Figure 1E]. To exclude the possibility that MA causes
γ oscillations in addition to KA-induced γ oscillations, we tested
the effect of MA in the absence of KA. Perfusion of MA alone
(20 µM) for 60 min had no effect on baseline oscillatory activity
(γ power in MA was 35.3± 9.4 µV2 vs. baseline 30.5± 10.2 µV2,
t(3) =−0.274, P = 0.802, example in Figures 1F,G). These results
indicate that MA strongly facilitates KA-induced γ oscillations.
The Effect of DR Antagonists on the
MA-Mediated Enhancement of γ
Oscillations
Methamphetamine increases excitatory synaptic transmission
in the hippocampus slice via activation of dopamine receptors
(Swant et al., 2010). To determine whether and which dopamine
receptor was involved in the MA-mediated enhancement of
γ oscillations, we tested the effect of the dopamine receptor
antagonists. In slices with stable γ oscillations, the DR1
antagonist SCH23390 (5 µM) was applied for 20 min, after
FIGURE 2 | SCH23390 blocked the MA-induced increase in γ oscillations. (A) Recordings from CA3 in the presence KA alone, KA + 10 µM SCH23390 (SCH) and
KA + 10 µM SCH23390 + 20 µM MA. (B) The power spectra of recordings in A. (C) γ power as percentage of preceding baseline for KA alone, KA + SCH23390
and KA + SCH23390 + MA (∗P < 0.05).
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FIGURE 3 | Raclopride blocked the MA-induced increase in γ oscillations. (A) CA3 recordings for KA alone, KA+ 10 µM Raclopride and KA+10 µM Raclopride +
20 µM MA. (B) The power spectra of recordings in A. (C) γ power as percentage of preceding baseline for KA alone, KA + Raclopride and KA+ Raclopride + MA.
which MA (20 µM) was added for 60 min. After 20 min in
SCH23390 γ power was 116 ± 4% of baseline, not different
from the control [t(8) = −1.929, P = 0.090, Figure 2]. Addition
of MA caused no significant change in γ power (105 ± 7% of
SCH23390, t(8) = −0.660, P = 0.528, Figure 2). These results
indicate that the DR1 antagonist largely blocked the effect of MA
on γ oscillations.
Similarly, the DR2 antagonist raclopride prevented the γ
oscillation-enhancing effect of MA. After 20 min in raclopride
(10 µM) γ power was 105 ± 5% of baseline, not different
from control [t(8) = −1.268, P = 0.240, Figure 3]. Addition
of MA (20 µM) did not enhance γ power [98 ± 5% of
raclopide, t(8) = 0.18, P = 0.861, Figure 3]. These results
indicate that the DR2 antagonist blocked the effect of MA
on γ oscillations. Therefore, our data suggest that both DR1
and DR2 are necessary for the MA-mediated enhancement of
γ oscillations.
The Effect of PKA Inhibition on the
MA-Mediated Enhancement of γ
Oscillations
Because DR1 and DR2 mediate PKA activity in opposite ways, we
tested the PKA inhibitor H89 on the MA-mediated enhancement
of γ oscillations. Application of H89 (10 µM) alone had no
effect on γ power (110 ± 4% of baseline, Figure 4), not different
from control [t(9) = −1.662, P = 0.131]. Further application MA
(20 µM) increased γ power by 120± 44% of H89 [t(9) =−2.647,
P = 0.027, Figure 4], not different from the effect of MA alone
[t(23) = −0.092, P = 0.927]. These results indicate that PKA was
not involved in the MA-induced effect on γ oscillations.
The Effect of ERK Inhibition on the
MA-Mediated Enhancement of γ
Oscillations
Because MA induces ERK phosphorylation in the hippocampus
(Cao et al., 2013) and ERK phosphorylation has been implicated
in psychosis (Pereira et al., 2014), we tested the effect of
the selective ERK inhibitor U0126 on the MA-mediated
enhancement of γ oscillations. U0126 (2.5 µM) did not affect
γ power [105 ± 6% of baseline, t(5) = −0.474, P = 0.660,
Figure 5]. Further application of MA (20 µM) increased γ power
by 152 ± 56% from U0126 [t(5) = −2.778, P = 0.039, Figure 5],
not different from the increase by MA alone [t(19) = −0.161,
P = 0.874]. The results show that the ERK was not involved in
MA-mediated enhancement of γ oscillations.
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FIGURE 4 | H89 does not affect the MA-induced increase in γ oscillations. (A) CA3 recordings for KA alone, KA + 10 µM H89 and KA + 10 µM H89 + 20 µM MA.
(B) The power spectra of the recordings in A. (C) γ power as percentage of preceding baseline for KA alone, KA + H89, KA + H89 + MA and KA + MA (∗P < 0.05,
∗∗P < 0.01, ns: not significant).
The Effect of PI3K Inhibition on the
MA-Mediated Enhancement of γ
Oscillations
Because PI3K is implicated in the effects of the MA analog
phentermine (Hong et al., 2016), we tested the effect of the PI3K
inhibitor wortmannin on the effect of MA on γ oscillations.
Application of wortmannin (200 nM) alone slightly increased
γ power (to 119 ± 10% of baseline, not different from the
control [t(7) = −1.359, P = 0.223]. Further application of MA
(20 µM) increased γ power by 137 ± 40% from wortmannin
[t(7) = −2.790, P = 0.027, Figure 6], not different from the
enhancement by MA alone [t(21) = −0.800, P = 0.432]. These
results indicate that PI3K was not involved in MA-mediated
enhancement of γ.
Effect of Akt Inhibition on the
MA-Mediated Enhancement of γ
Oscillations
Because MA activates Akt (Nohesara et al., 2016), we tested
the effect of the Akt inhibitor triciribine on the MA-mediated
enhancement of γ oscillations.
Application of triciribine (5 µM) did not affect γ power
[103 ± 4% of baseline, t(7) = 0.104, P = 0.920, Figure 7].
Further application of MA (20 µM) did not affect γ oscillations
consistently; γ power was 120± 27% of triciribine [t(7) =−0.612,
P = 0.560, Figure 7]. These results show that Akt activation is
required for MA-mediated enhancement of γ oscillations.
The Effect of NMDA Receptor Antagonist
on MA-Regulated γ Oscillations
The NMDA receptor plays a critical role in excitatory synaptic
neurotransmission and plasticity, and NMDAR antagonists
can cause hallucinations and increases in γ oscillations in
hippocampus, nucleus accumbens and prefrontal cortex (Lee
et al., 2017). We tested the effect of the NMDA receptor
antagonist D-AP5 on the MA-mediated enhancement of γ
oscillations. Application of D-AP5 (10 µM) alone slightly
increased γ power (to 116 ± 5% of baseline, not different from
the control t(6) = −1.438, P = 0.200, Figure 8). Addition of
MA (20 µM) had no consistent effect on γ oscillations [γ power
was 111 ± 13% of D-APV, t(6) = −1.065, P = 0.328, Figure 8].
These results indicate that NMDAR activation is necessary for
MA-regulated γ enhancement.
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FIGURE 5 | U0126 does not affect the MA-induced increase in γ oscillations. (A) CA3 recordings for KA alone, KA + 2.5 µM U0126 and KA + 2.5 µM U0126 +
20 µM MA. (B) The power spectra for the recordings in A. (C) γ power as percentage of preceding baseline for KA alone, KA+ U0126, KA+ U0126 + MA and
KA+MA (∗P < 0.05, ns: not significant).
DISCUSSION
Our results demonstrate that MA increases hippocampal γ
oscillation strength in vitro, is dependent on both DR1 and DR2
activation, Akt activity and NMDAR activity, but not on ERK,
PI3K or PKA activity.
Signaling Pathways Involved in the
MA-Mediated Enhancement of γ
Oscillations
Methamphetamine increases dopamine concentrations in the
tissue (Ares-Santos et al. (2013), probably through activation
of trace amine-associated receptor 1, which inhibits uptake and
promoting eﬄux by monoamine transporters (Miller, 2011).
Both DR1 and DR2 antagonists blocked the effect of MA on γ
power in this study, suggesting the involvement of both DR1 and
DR2 in the MA-mediated γ oscillation enhancement. It is known
that activation of the DR2-type DR4 increases hippocampal γ
power (Andersson et al., 2012). Our results indicate DR1 plays
a similar role as DR2 in the regulation of γ oscillations. This
is in line with the observation that both selective DR1 and
DR2 antagonists reverse MA-induced motor effects (Ujike et al.,
1989). It is, however, surprising that the two DR antagonists
have a similar effect on the MA-mediated modulation of γ
oscillations, given that they have an opposite effect on cAMP-
PKA signaling. It is possible that the opposing effect of two
DRs on adenylyl cyclase may limit the PKA activity and the
role of PKA on MA-mediated γ oscillations. In support of this
notion, MA does not alter the expression of PKA catalytic subunit
in hippocampus (Hayashi et al., 2010). Interestingly, both DR1
and DR2 agonists can increase phosphorylation levels of Akt
(Brami-Cherrier et al., 2002).
The sensitivity to Akt inhibition reported here, suggests that
MA enhancement of γ oscillations involves Akt signaling. This
is in line with the observation that acute MA increases the
Akt phosphorylation in cultured hippocampal neurons (Rau
et al., 2011) and that MA-induced psychosis is associated with
increased expression of Akt1, one of the three Akt isoforms
(Nohesara et al., 2016). Phentermine, structurally similar to MA,
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FIGURE 6 | Wortmannin does not affect the MA-induced increase in γ oscillations. (A) CA3 recordings for KA alone, KA + 0.2 µM wortmannin (Wort) and KA +
0.2 µM wortmannin + 20 µM MA. (B) The power spectra for the recordings in A. (C) γ power as percentage of preceding baseline for KA alone, KA+ Wortmannin,
KA + Wortmannin + MA and KA + MA (∗P < 0.05, ns: not significant).
induces conditional rewarding effects via activation of PI3K/Akt
signaling in the NAc (Hong et al., 2016). However, in our
experiments, PI3K inhibition did not affect the MA-modulation
of γ oscillations. It is therefore possible that MA activates PI3K-
independent Akt signaling (Brami-Cherrier et al., 2002).
Instead of PI3K, ERK may be an alternative upstream
molecule of Akt (Brami-Cherrier et al., 2002). However, our
results don’t support the involvement of ERK in MA-mediated
enhancement of γ oscillations.
Taken together, our observations indicate that the MA-
mediated enhancement of γ oscillations acts through DR1/DR2-
mediated Akt activation (Figure 9). Our results are in agreement
with previous reports (Mannoury la Cour et al., 2011; Swift
et al., 2011; Chen et al., 2012) but not with DR2-mediated Akt
inhibition (Beaulieu et al., 2007b). The exact mechanism for
DR-induced activation of Akt remains therefore to be further
investigated. One of the possibilities is that DR1 or DR2 activates
Akt via receptor tyrosine kinase (RTK) transactivation (Beaulieu
et al., 2011), as it has been shown that stimulation of DR1 or DR2
causes activation of the epidermal growth factor receptor or TrkB
RTK (Swift et al., 2011).
In addition to dopamine, MA also increases tissue levels
of norepinephrine and serotonin. However, if anything,
norepinephrine suppresses kainate-induced oscillations in vitro
(Wojtowicz et al., 2009) and norepinephrine released from the
locus coeruleus inhibits gamma in vivo (Walling et al., 2011).
This may be explained by the suppression of excitatory synaptic
transmission in hippocampus by norepinephrine (Scanziani
et al., 1993). Serotonin also suppresses kainate-induced
oscillations (Wojtowicz et al., 2009; Johnston et al., 2014). Thus,
although we have not tested the role of norepinephrine or
serotonin in current study, neither NE nor serotonin are likely
to contribute to the MA-mediated enhancement of hippocampal
γ oscillations.
Role of NMDAR on the MA-Mediated
Enhancement of γ Oscillations
The dependence on NMDAR activity of the MA-mediated
enhancement of γ oscillations in our experiments, suggest a
crucial role for NMDAR-linked signaling. This is in agreement
with the MA-induced enhancement of NMDA currents in
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FIGURE 7 | Triciribine blocked the MA-induced increase in γ oscillations. (A) CA3 recordings for KA alone, KA+ 5 µM triciribine and KA+5 µM triciribine +20 µM MA.
(B) The power spectra for the recordings in A. (C) γ power as percentage of preceding baseline for KA, KA + triciribine and KA + triciribine + MA and KA + MA.
mesencephalic dopamine neurons (Li et al., 2017) and with the
MA-induced increase in NR1 expression in the striatum (Kerdsan
et al., 2009). We previously demonstrated the involvement of
NMDAR in γ enhancement mediated by low concentrations of
the stimulant nicotine (Wang et al., 2015).
Interestingly, Akt activity is dynamically regulated by synaptic
activity that is coupled to NMDA receptor activation (Sutton
and Chandler, 2002). Akt-mediated NMDAR activation is via
phosphorylation of the NMDAR subunit NR2C (Sanchez-
Perez et al., 2006; Chen and Roche, 2009). The MA-mediated
enhancement of γ oscillations is therefore likely due to Akt-
mediated activation of NMDARs (Figure 9). In addition, MA
may activate NMDARs by increasing extracellular glutamate
concentration via neuronal excitatory amino acid transporter 3
internalization (Li et al., 2017).
Possible Mechanism Underlying the
MA-Mediated Enhancement of γ
Oscillations
CA3 γ oscillations emerge from the interplay between fast-
firing parvalbumin-expressing interneurons and pyramidal cells
(Mann and Paulsen, 2005; Bartos et al., 2007). Activation of Akt
may enhance γ oscillations through an increase in postsynaptic
GABAA receptor density and GABAergic synaptic transmission
(Wang et al., 2003; Chen et al., 2014; Figure 9). Alternatively,
modulation of NMDAR activity may affect γ oscillations, because
parvalbumin-expressing interneurons, express NMDARs, which
provide tonic depolarization and thus drive γ oscillations (Carlen
et al., 2012; Figure 9).
Functional Implications of the
MA-Mediated Enhancement of γ
Oscillations
Although our observations are based on the isolated γ oscillation-
generating CA3 network in the in vitro kainate model, it is likely
that similar MA-mediated enhancement γ oscillations will take
place in vivo, where modulation by midbrain and brainstem
inputs adds a level of complexity.
The MA-induced enhancement of γ oscillations is in line with
the observation that MA treatment increases γ oscillations in
the NAc of freely moving rats (Morra et al., 2012) and that
amphetamine or the dopamine agonist apomorphine increases
γ power in the rat neocortex (Pinault, 2008). These studies
suggest that MA can enhance γ oscillations in multiple mutually
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FIGURE 8 | D-AP5 blocked the MA-induced increase in γ oscillations. (A) CA3 recordings for the presence KA alone, KA+ 10 µM D-AP5 and KA+10 µM D-AP5 +
20 µM MA. (B) The power spectra for the recordings in A. (C) γ power as percentage of preceding baseline for KA alone, KA+ D-AP5 and KA+ D-AP5 + MA.
FIGURE 9 | Diagram showing the possible mechanisms for MA-mediated
enhancement ofγ oscillations. MA increases dopamine levels, which activates
both DR1 and DR2 (green arrow 1, indicating activation), which causes
transactivation of receptor tyrosine kinase (RTK) (2), and downstream kinase
Akt phosphorylation (3). Akt activation increases postsynaptic GABAA
receptors (4) and activates NMDAR (5), which may also activate Akt (6). In
addition MA can increase glutamate levels that activate NMDA receptors (7).
NMDAR activation and the increased GABAAR expression can both
contribute to the enhancement of γ oscillations.
connected brain areas. γ oscillations have been suggested to
synchronize the activity of neural ensembles and to control the
information flow within and between anatomically connected
networks (Konig et al., 1995; Womelsdorf et al., 2007; Colgin,
2011; Buzsaki and Wang, 2012; Akam and Kullmann, 2014;
Fries, 2015). These studies suggest that MA can enhance γ
oscillations in functionally connected brain areas involved in
psychosis (Ma and Leung, 2010; Lee et al., 2017), which may cause
aberrantly strong connectivity between these areas, contributing
to MA-induced psychosis in normal subjects (Wearne and
Cornish, 2018). In subjects with low levels of attention, the MA-
mediated enhancement of γ oscillations may restore functional
connectivity and increase attention, which may explain the use of
MA in the treatment of attention-deficit hyperactivity disorder in
children (Hart et al., 2012).
In addition to dopamine, MA increases norepinephrine and
serotonin levels (Rothman et al., 2001), which may contribute to
MA-induced psychosis in humans and psychosis-like repetitive
behaviors in animals (Morra et al., 2010).
It is worth to mention that the enhancement of γ oscillations
by acute MA is mechanistically different from the effect of other
psychostimulants such as ketamine, which also increases cortical
γ power and causes cognitive deficits and psychosis (Furth et al.,
2017). In contrast to ketamine, acute MA enhancement of γ
power is associated with NMDAR activation. This difference
may explain why ketamine is associated with impaired cognitive
function, whereas acute MA is associated with improved spatial
memory in human addicts (Mahoney et al., 2011, Rau et al., 2012)
and enhanced synaptic plasticity in rodents (Hori et al., 2010).
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